ChemPacific
Private Company
Total funding raised: $3.5M
Overview
ChemPacific is a privately held, revenue-generating chemical services company that operates at the intersection of the small molecule and drug delivery sectors. Its core business model is built on providing custom synthesis and manufacturing services, utilizing a dual-geography infrastructure in the US and China to offer cost-effective, scalable production from R&D to bulk quantities. The company serves a broad clientele, including pharmaceutical, agrochemical, and industrial sectors, by acting as a managed sourcing and production partner. Its value proposition centers on deep knowledge of the Chinese chemical marketplace combined with Western project management and quality standards.
Technology Platform
Integrated US-China service platform for custom chemical synthesis, featuring American project management coupled with manufacturing in China, supported by digital inventory and structure search tools.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ChemPacific competes in a crowded field including large, publicly-traded CDMOs (e.g., Lonza, Catalent), pure-play chemistry CDMOs (e.g., Piramal, Cambrex), and a vast array of Chinese chemical manufacturers and sourcing agents. Its differentiation lies in its positioned role as a managed gateway to Chinese chemistry, offering more hands-on oversight and integration than a simple broker but at a lower cost structure than a fully Western-based CDMO.